About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 6642 record(s)
Req # A-2021-000647
Adverse Reaction Reports (AERs) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: 000925314, 000925609, 000921918, 000921884, 000923476, 000922360, 919535.Organization: Health Canada
August 2021
Req # A-2021-000651
Adverse Reaction Reports (AERs) for DEFLAZACORT. Report numbers: 000931491, 000931913, 000931514, 000931826.Organization: Health Canada
August 2021
Req # A-2021-000652
Adverse Reaction Reports (AERs) for ENOXAPARIN SODIUM. Report numbers: 918743, 921189, 921768, 922174, 921461, 921607.Organization: Health Canada
August 2021
Req # A-2021-000658
Adverse Drug Reaction (ADR) for POLYSTYRENE SULFONATE SODIUM. Report number: 000924985.Organization: Health Canada
August 2021
Req # A-2021-000669
Adverse Drug Reaction (ADR) for LEVOMEPROMAZINE MALEATE. Report number: 000920812.Organization: Health Canada
August 2021
Req # A-2021-000670
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: 000921603.Organization: Health Canada
August 2021
Req # A-2021-000672
Adverse Drug Reaction (ADR) for PREDNISOLONE SODIUM PHOSPHATE. Report number: E2B_03278670.Organization: Health Canada
August 2021
Req # A-2021-000675
Adverse Reaction Reports (AERs) for DUPILUMAB. Report numbers: E2B_03467962, E2B_03417694.Organization: Health Canada
August 2021
Req # A-2021-000676
Adverse Drug Reaction (ADR) for CYTARABINE. Report number: 919319.Organization: Health Canada
August 2021
Req # A-2021-000690
Adverse Drug Reaction (ADR). Report number: 000941436.Organization: Health Canada
August 2021